Healthcare
SPYRE THERAPEUTICS INC
Ticker: SYRE
|
Exchange: US
|
Composite FIGI: BBG0067L94B2
Total Alternative Signals
1signals tracked
Weighted Sentiment
0.00weighted index
Avg Materiality Score
3.0/ 5.0 scale
Signal Distribution
0▲|1■|0▼
Alternative Data Signal Feed
Unlock Alternative Signals Feed
Access the complete, parsed materiality analysis, long-term investment theses, and direct feed links for SPYRE THERAPEUTICS INC. Programmatic API and Webhooks available.
Talent PivotNeutral
Filing Date: 2026-06-20
Signal Event Report - FIGI BBG0067L94B2
SPYRE THERAPEUTICS INC filed an 8-K report detailing changes in its directors or certain officers, which could involve appointments or departures, and also reported on matters submitted to a vote of security holders.
Quantitative Investment Thesis
Changes in key personnel, such as directors or officers, can signal shifts in company strategy or operational focus, warranting close observation for their potential long-term effects on the company's direction and performance.
Materiality & Sentiment Scores
Sentiment: 0
Materiality: 3 / 5
Source Document: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000056/0001636282-26-000056-index.htm